KHRNF Khiron Life Sciences Corp.

Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America. It operates through four business units: Pharma Medical, Khiron Clinics, Wellness, and Dixie JV. The company focuses on the cultivation, production, distribution, and export of THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. It also develops CBD-based cosmeceutical products for women and men's categories; and operates the company owned medical clinics. In addition, the company develops cannabis products in the food and beverage, supplements, and pets categories. The company was founded in 2017 and is headquartered in Vancouver, Canada.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol CV:KHRN.

$0.17    OTCQX
As of 11/29/2021     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  
IPO date:  05/29/2018
Outstanding shares:  179,117,068
Average volume:  234,002
Market cap:   $31,811,191
Current dividend yield:  0.00%
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -1.99
PB ratio:   0.58
PS ratio:   2.72
Return on equity:   -29.09%
Net income %:   -137.04%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy